tradingkey.logo
tradingkey.logo
Search

Avidity Biosciences Inc

RNA
Add to Watchlist
13.480USD
-0.230-1.68%
Close 08-20 16:00ET
1.63BMarket Cap
LossP/E TTM

RNA Financials

See Avidity Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Avidity Biosciences Inc Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
-1.21/-0.99
Revenue / Forecast
3.85M/1.47M
Period
FY2025 Earnings
Revenue(YoY)
18.62M
70.85%
EPS(YoY)
-2.89
-0.13%
Analyst Rating
BUY
2026/08/20
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
2.77%-1.18
-8.54%-0.97
-114.14%-1.70
-94.12%-1.27
-83.31%-1.21
-13.47%-0.90
-0.08%-0.80
7.78%-0.65
-0.51%-0.66
-6.13%-0.79
9.73%-0.79
---0.71
---0.66
---0.74
---0.88
---2.45
----
----
----
----
Revenue
-21.91%3.00M
1148.25%19.64M
-71.11%859.00K
434.03%12.47M
88.12%3.85M
-55.60%1.57M
35.57%2.97M
-17.10%2.34M
-11.70%2.04M
58.67%3.54M
-20.80%2.19M
13.54%2.82M
6.34%2.32M
24.40%2.23M
49.51%2.77M
14.75%2.48M
-16.46%2.18M
-33.62%1.79M
-13.54%1.85M
23.88%2.16M
Net Profit
87.17%-20.19M
-123.29%-16.63M
71.51%-29.14M
-116.97%-174.44M
-122.22%-157.31M
-68.14%-115.77M
-69.18%-102.26M
-53.55%-80.40M
-50.54%-70.79M
-31.42%-68.86M
-19.76%-60.44M
-20.09%-52.36M
-2.92%-47.02M
-53.04%-52.39M
-30.96%-50.47M
-48.93%-43.60M
-73.38%-45.69M
-43.58%-34.23M
-136.79%-38.54M
-155.91%-29.27M
Net Margin
83.57%-671.97%
98.85%-84.71%
1.39%-3391.85%
59.37%-1398.33%
-18.13%-4089.29%
-278.72%-7360.01%
-24.79%-3439.52%
-85.24%-3441.70%
-70.49%-3461.76%
17.17%-1943.41%
-51.21%-2756.18%
---1857.98%
---2030.44%
---2346.35%
---1822.72%
---1913.62%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
Revenue
-21.91%3.00M
1148.25%19.64M
-71.11%859.00K
434.03%12.47M
88.12%3.85M
-55.60%1.57M
35.57%2.97M
-17.10%2.34M
-11.70%2.04M
58.67%3.54M
-20.80%2.19M
13.54%2.82M
6.34%2.32M
24.40%2.23M
49.51%2.77M
14.75%2.48M
-16.46%2.18M
-33.62%1.79M
-13.54%1.85M
23.88%2.16M
Operating profit
86.78%-22.62M
-131.88%-17.28M
75.95%-29.10M
-92.40%-188.81M
-107.13%-171.14M
-70.39%-131.52M
-81.28%-120.99M
-67.39%-98.13M
-56.98%-82.63M
-34.01%-77.19M
-25.40%-66.74M
-30.48%-58.63M
-13.68%-52.63M
-67.14%-57.60M
-38.08%-53.23M
-53.45%-44.93M
-75.59%-46.30M
-44.44%-34.46M
-136.59%-38.55M
-155.36%-29.28M
Net Profit
87.17%-20.19M
-123.29%-16.63M
71.51%-29.14M
-116.97%-174.44M
-122.22%-157.31M
-68.14%-115.77M
-69.18%-102.26M
-53.55%-80.40M
-50.54%-70.79M
-31.42%-68.86M
-19.76%-60.44M
-20.09%-52.36M
-2.92%-47.02M
-53.04%-52.39M
-30.96%-50.47M
-48.93%-43.60M
-73.38%-45.69M
-43.58%-34.23M
-136.79%-38.54M
-155.91%-29.27M
Current assets
-78.01%275.05M
-80.10%285.56M
-99.82%2.85M
21.22%1.97B
-5.89%1.25B
53.56%1.43B
152.29%1.54B
191.97%1.62B
123.50%1.33B
56.49%934.47M
-1.87%611.31M
34.03%555.49M
47.07%594.53M
47.52%597.15M
51.52%622.94M
-1.78%414.46M
40.70%404.25M
29.76%404.80M
23.96%411.14M
22.56%421.96M
Total current liabilities
-76.67%31.51M
-74.19%21.91M
-57.35%41.80M
86.00%169.88M
60.38%135.06M
13.22%84.86M
21.49%98.02M
87.48%91.33M
86.13%84.21M
55.88%74.95M
55.43%80.68M
14.18%48.72M
34.31%45.24M
55.51%48.09M
75.02%51.91M
90.32%42.67M
106.19%33.69M
76.54%30.92M
103.32%29.66M
63.87%22.42M
Total assets
-79.51%280.51M
-79.96%292.36M
-99.47%8.35M
30.07%2.13B
1.60%1.37B
53.35%1.46B
148.81%1.56B
186.27%1.64B
120.61%1.35B
54.97%951.47M
-1.60%628.55M
33.13%573.16M
45.15%610.78M
45.79%613.98M
49.40%638.80M
1.09%430.54M
44.84%420.80M
33.80%421.13M
28.06%427.58M
23.05%425.92M
Total liabilities
-62.59%65.94M
-55.31%58.26M
-48.85%71.07M
80.47%247.94M
39.46%176.26M
8.11%130.35M
8.72%138.94M
146.68%137.39M
144.91%126.39M
118.98%120.58M
110.44%127.79M
3.99%55.70M
11.10%51.61M
21.21%55.06M
31.58%60.73M
72.54%53.56M
78.36%46.45M
58.64%45.43M
66.76%46.15M
19.53%31.04M
Total equity
-82.01%214.58M
-82.38%234.10M
-104.40%-62.71M
25.47%1.89B
-2.32%1.19B
59.91%1.33B
184.56%1.42B
190.53%1.50B
118.36%1.22B
48.66%830.90M
-13.37%500.76M
37.27%517.47M
49.37%559.18M
48.76%558.91M
51.55%578.08M
-4.53%376.98M
41.54%374.35M
31.31%375.71M
24.56%381.43M
23.34%394.88M
Net operating income
98.03%-3.93M
-180.49%-31.14M
80.72%-19.25M
-138.01%-156.17M
-207.16%-199.67M
-77.36%-124.83M
-705.24%-99.87M
-78.35%-65.61M
-30.51%-65.00M
-43.73%-70.38M
142.11%16.50M
-15.12%-36.79M
-40.12%-49.81M
-65.57%-48.97M
-49.49%-39.19M
-53.78%-31.96M
-26.34%-35.55M
-50.27%-29.57M
-100.53%-26.21M
-128.05%-20.78M
Net investment
-203.29%-191.59M
-101.33%-2.10M
98.63%-879.00K
-21.87%-587.93M
167.48%185.49M
580.01%157.19M
-225.73%-64.17M
-1432.49%-482.41M
-696.91%-274.87M
83.27%-32.75M
757.05%51.04M
-387.95%-31.48M
360.99%46.05M
-11.51%-195.68M
90.76%-7.77M
1466.50%10.93M
-714.35%-17.64M
-33323.81%-175.47M
-1113.04%-84.06M
5.33%-800.00K
Net financing
-100.00%0.00
2615.53%301.50M
46.68%20.13M
148.31%850.37M
-99.16%3.77M
-99.50%1.94M
-56.97%13.72M
856060.00%342.46M
1046.27%446.72M
1596.12%389.44M
-86.91%31.89M
-99.90%40.00K
0.48%38.97M
-4.78%22.96M
1076.28%243.65M
-74.47%39.62M
9290.80%38.78M
141741.18%24.11M
4503.11%20.71M
11628.38%155.17M

FAQs

What is the total revenue of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its total revenue reached 18.62M, with a year-on-year change of 10.90M.

What are the current assets of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its current assets were 2.85M, with a year-on-year change of 489.03.

What are the total assets of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its total assets of Avidity Biosciences Inc were 8.35M, with a year-on-year change of 16.24.

What are the total liabilities of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its total liabilities of Avidity Biosciences Inc were 71.07M, with a year-on-year change of 4.06.

What is the total equity of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its total equity of Avidity Biosciences Inc was -62.71M, with a year-on-year change of -2.63.

What is the net operating income of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its net operating income of Avidity Biosciences Inc was -49.63M, with a year-on-year change of -275.48.

What is the net investment of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its net investment of Avidity Biosciences Inc was -1.45M, with a year-on-year change of -443.23.

What is the net financing of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its net financing of Avidity Biosciences Inc was 42.57M, with a year-on-year change of 86.57.

What is the Earnings Per Share (EPS) of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.89, with a year-on-year change of -0.13.

What is the net income of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its net income was -49.50M, with a year-on-year change of -97.04.

What is the net margin of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its net profit margin was -265.88, with a year-on-year change of 91.01.

What is the Return on Equity (ROE) of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -43.98, with a year-on-year change of -31.38.

What is the Return on Assets (ROA) of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -637.12, with a year-on-year change of -2066.99.

What is the operating profit of Avidity Biosciences Inc?

According to Avidity Biosciences Inc's FY2025 earnings report, its operating profit was -49.63M, with a year-on-year change of -275.48.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.